(4E,14S,15R,18E,20E)-22-ethyl-11,14,15-trihydroxy-6'-(2-hydroxybutyl)-5',6,7,8,10,12,14,16,28,29-decamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酯类和类似物
• 英文名称: (4E,14S,15R,18E,20E)-22-ethyl-11,14,15-trihydroxy-6'-(2-hydroxybutyl)-5',6,7,8,10,12,14,16,28,29-decamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione
• 化学式: C₄₇H₇₈O₁₀
• 分子量: 803.1
• InChiKey: QXJKCKLLLSLMKM-CYUMZFLBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9
• 重原子数：
  57
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  160
• 氢给体数：
  4
• 氢受体数：
  10

文献信息

• Small molecule immunopotentiators and assays for their detection
  申请人：Valiante Nicholas

  公开号：US20110104186A1

  公开（公告）日：2011-05-05

  The invention provides immunostimulatory compositions comprising a small molecule immuno-potentiator (SMIP) compound and methods of administration thereof. Also provided are methods of administering a SMIP compound in an effective amount to enhance the immune response of a subject to an antigen. Further provided are novel compositions and methods of administering SMIP compounds alone or in combination with another agent for the treatment of cancer, infectious diseases and/or allergies/asthma. In a further aspect, the invention relates generally to methods of screening for small molecule immuno-modulatory compositions.